Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 2/20 | 0.69 |
| ▸ | FADS1 | O60427 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | APEX1 | P27695 | 1/20 | 0.58 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 5/20 | 0.54 |
| ▸ | NPC1 | O15118 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30830441 | 1.00 | PTGS1 (0.69) | PTGS1FADS1MEN1KMT2ALMNA | |
| SCHEMBL17744848 | 0.94 | PTGS1 (0.75) | PTGS1FADS1MEN1KMT2ALMNA | |
| SCHEMBL17744771 | 0.93 | POLB (0.71) | PTGS1FADS1MEN1KMT2ALMNA | |
| SCHEMBL8402954 | 0.90 | KMT2A (0.64) | PTGS1MEN1KMT2ALMNATDP1 | |
| SCHEMBL1140055 | 0.89 | PTGS1 (0.68) | PTGS1FADS1MEN1KMT2ALMNA | |
| SCHEMBL4954215 | 0.87 | PTGS1 (0.67) | PTGS1FADS1MEN1KMT2ALMNA | |
| SCHEMBL4957349 | 0.87 | LMNA (0.69) | PTGS1FADS1MEN1KMT2ALMNA | |
| SCHEMBL5853941 | 0.86 | PTGS1 (0.65) | PTGS1FADS1MEN1KMT2ALMNA | |
| SCHEMBL15361168 | 0.86 | SMN1; SMN2 (0.68) | PTGS1FADS1MEN1KMT2ALMNA | |
| SCHEMBL1961988 | 0.86 | FADS1 (0.73) | PTGS1FADS1MEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220011485-A1 | CURABLE COMPOSITION, LIGHT-SHIELDING FILM, COLOR FILTER, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING ELEMENT, AND INFRARED SENSOR | FUJIFILM CORPORATION (JP) | 2022-01-13 | — | — | US | disclosed |
| US-11156754-B2 | Curable composition, light-shielding film, color filter, pattern forming method, method for manufacturing color filter, solid-state imaging element, and infrared sensor | FUJIFILM CORPORATION (JP) | 2021-10-26 | — | — | US | disclosed |
| US-10752624-B2 | Kinase inhibitors | ORIGENIS GMBH (DE) | 2020-08-25 | — | — | US | disclosed |
| US-10209554-B2 | Method for manufacturing laminated resin black-matrix substrate | TORAY INDUSTRIES, INC. (JP) | 2019-02-19 | — | — | US | disclosed |
| US-20190018174-A1 | CURABLE COMPOSITION, LIGHT-SHIELDING FILM, COLOR FILTER, PATTERN FORMING METHOD, METHOD FOR MANUFACTURING COLOR FILTER, SOLID-STATE IMAGING ELEMENT, AND INFRARED SENSOR | FUJIFILM CORPORATION (JP) | 2019-01-17 | — | — | US | disclosed |
| US-20180305356-A1 | NOVEL KINASE INHIBITORS | ORIGENIS GMBH (DE) | 2018-10-25 | — | — | US | disclosed |
| US-10000482-B2 | Kinase inhibitors | ORIGENIS GMBH (DE) | 2018-06-19 | — | — | US | disclosed |
| US-9637491-B2 | Pyrazolo[4,3-D]pyrimidines as kinase inhibitors | ORIGENIS GMBH (DE) | 2017-05-02 | — | — | US | disclosed |
| EP-2444376-B1 | BLACK COMPOSITE PARTICLE, BLACK RESIN COMPOSITION, COLOR FILTER SUBSTRATE AND LIQUID CRYSTAL DISPLAY | TORAY INDUSTRIES (JP) | 2017-01-25 | — | — | EP | disclosed |
| US-20160370646-A1 | METHOD FOR MANUFACTURING LAMINATED RESIN BLACK-MATRIX SUBSTRATE | TORAY INDUSTRIES, INC. (JP) | 2016-12-22 | — | — | US | disclosed |
| WO-2014060112-A1 | PYRAZOLO[4,3-D]PYRIMIDINES AS KINASE INHIBITORS | ORIGENIS GMBH (DE) | 2014-04-24 | — | — | WO | disclosed |
| WO-2014060113-A1 | NOVEL KINASE INHIBITORS | ORIGENIS GMBH (DE) | 2014-04-24 | — | — | WO | disclosed |
| US-8329068-B2 | Black resin composition, resin black matrix, color filter and liquid crystal display | TORAY INDUSTRIES, INC. (JP) | 2012-12-11 | — | — | US | disclosed |
| US-20120128898-A1 | BLACK COMPOSITE PARTICLE, BLACK RESIN COMPOSITION, COLOR FILTER SUBSTRATE AND LIQUID CRYSTAL DISPLAY | TORAY INDUSTRIES, INC. (JP) | 2012-05-24 | — | — | US | disclosed |
| EP-2444376-A1 | BLACK COMPOSITE PARTICLE, BLACK RESIN COMPOSITION, COLOR FILTER SUBSTRATE AND LIQUID CRYSTAL DISPLAY | Toray Industries, Inc. (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-20100038606-A1 | BLACK RESIN COMPOSITION, RESIN BLACK MATRIX, COLOR FILTER AND LIQUID CRYSTAL DISPLAY | TORAY INDUSTRIES, INC. (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2135900-A1 | BLACK RESIN COMPOSITION, RESIN BLACK MATRIX, COLOR FILTER AND LIQUID CRYSTAL DISPLAY | Toray Industries, Inc. (JP) | 2009-12-23 | — | — | EP | disclosed |
| US-20030036653-A1 | Diaminopyridine-containing thiourea inhibitors of herpes viruses | AMERICAN HOME PRODUCTS CORPORATION | 2003-02-20 | — | — | US | disclosed |
| US-20020026055-A1 | Aminopyridine-containing thiourea inhibitors of herpes viruses | AMERICAN HOME PRODUCTS CORPORATION | 2002-02-28 | — | — | US | disclosed |
| US-20010039348-A1 | Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group | AMERICAN HOME PRODUCTS CORPORATION (US) | 2001-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180305356-A1 | NOVEL KINASE INHIBITORS | LRRK2, MYLK2, MYLK | PTGS1 2100/4885FADS1 4381/4885MEN1 544/4885 |
| US-20030036653-A1 | Diaminopyridine-containing thiourea inhibitors of herpes viruses | HAVCR2, CCR6, CXCR6 | PTGS1 4336/4885FADS1 4455/4885MEN1 4810/4885 |
| US-20010039348-A1 | Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group | CCR6, HAVCR2, BCOR | PTGS1 3433/4885FADS1 4390/4885MEN1 4755/4885 |
| US-20020026055-A1 | Aminopyridine-containing thiourea inhibitors of herpes viruses | TK1, TPMT, CXCR6 | PTGS1 3088/4885FADS1 4786/4885MEN1 4601/4885 |
| US-10000482-B2 | Kinase inhibitors | LRRK2, MYLK2, MYLK | PTGS1 1996/4885FADS1 4412/4885MEN1 636/4885 |
| US-10752624-B2 | Kinase inhibitors | LRRK2, MYLK2, MYLK | PTGS1 1996/4885FADS1 4412/4885MEN1 636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.